fda sued over tirzepatide Judge says compounding pharmacies must stop making copies of Zepbound, Mounjaro FDA Approves Tirzepatide, A Potential

D., Nunes M

Is there a difference in weight gain for younger women versus older women after a hysterectomy

Injectable use in humans represents off-label experimental application with limited long-term human safety data specifically for injectable formulations

Cholesterol drug decreases incidence of major adverse cardiac events by over 20% December 8, 2025 Summary: A new study shows that an injectable anticholesterol drug significantly lowers the risk of major adverse cardiovascular events

Up until now, bariatric surgery, a very invasive surgical procedure, has been the only intervention to demonstrate good success in sustained weight loss